Mikie Suzuki

405 citations
8 papers · 335 indexed · h-index 5
Topics
Pharmacogenetics and Drug Metabolism (3 papers)Drug Transport and Resistance Mechanisms (3 papers)Immune Response and Inflammation (3 papers)
Partner nations
Japan

In The Last Decade

Mikie Suzuki

8 papers receiving 320 citations

Peers

Mikie Suzuki
Comparison fields: 5 of 65
  • Pharmacology 215
  • Oncology 100
  • Molecular Biology 81
  • Pharmacology 55
  • Cardiology and Cardiovascular Medicine 47
Replace Faraz Kazmi with:
Faraz Kazmi United States
Paul Toren United States
Phyllis Yerino United States
Quan Zhou China
Francis Heitz Switzerland
Donald E. Slaughter United States
Richard Fux Germany
Lisa Gillen United States
Jianghua Tu China
Mikie Suzuki relative to Faraz Kazmi United States Faraz Kazmi's profile →
Citations per field
00.5×1.5×
Faraz Kazmi · 1×
Citations per year

Countries citing papers authored by Mikie Suzuki

Since Specialization
Citations

This map shows the geographic impact of Mikie Suzuki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mikie Suzuki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mikie Suzuki more than expected).

Fields of papers citing papers by Mikie Suzuki

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mikie Suzuki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mikie Suzuki. The network helps show where Mikie Suzuki may publish in the future.

Co-authorship network of co-authors of Mikie Suzuki

This figure shows the co-authorship network connecting the top 25 collaborators of Mikie Suzuki. A scholar is included among the top collaborators of Mikie Suzuki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mikie Suzuki. Mikie Suzuki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
#WorkIndexed citations
1 7
2
Pathophysiological studies of trinitrobenzene sulfonic acid-induced colitis in Syrian hamsters (Mesocricetus auratus).
2
3 4
4 2
5 163
6 23
7 133
8 1

About Mikie Suzuki

Mikie Suzuki is a scholar working on Pharmacology, Immunology and Biochemistry, having authored 8 papers that have together received 335 indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (3 papers), Drug Transport and Resistance Mechanisms (3 papers) and Immune Response and Inflammation (3 papers). The work is most often cited by research in Pharmacology (215 citations), Biochemistry (35 citations) and Oncology (100 citations). Mikie Suzuki has collaborated with scholars based in Japan. Frequent co-authors include Noriaki Shimada, Tsuyoshi Yokoi, Hiroshi Yamazaki, Katsuhiro Ohyama, Mitsutoshi Nakajima, Masatoshi Nakajima, F. Peter Guengerich, Yasushi Hirota, Nobuo Katsube and Ryoichi Yamaji. Their work appears in journals such as British Journal of Clinical Pharmacology, Drug Metabolism and Disposition and Neuroradiology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026